Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
SHL Medical announces plans to establish SHL Advantec
SHL Medical's existing tooling and automation operations will be integrated into SHL Advantec, bringing their range of technologies, services, and equipment portfolio to the new business. Together with SHL Medical's recent strategic acquisitions – Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling – SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec's diverse…
PR Newswire
21/11/2024
Vicebio Advances Clinical Study of RSV/hMPV Bivalent Vaccine & Strengthens Board…
Moncef Slaoui, PhD, and Khurem Farooq join the Board of Directors, effective immediately. Both bring vast experience in vaccine development and biopharmaceutical leadership. Moncef Slaoui, PhD, and Khurem Farooq join the Board of Directors, effective immediately. Both bring vast experience in vaccine development and biopharmaceutical leadership. Emmanuel Hanon, Chief Executive Officer of Vicebio, said: "In connection with our significant Series B financing, we are building upon our...
PR Newswire
21/11/2024
RSNA 2024 spotlight: Sectra showcases how radiologists can gain increased…
In booth #8113, Sectra will showcase its complete enterprise imaging portfolio comprised of diagnostic modules (radiology, cardiology, pathology, orthopaedics, ophthalmology and genomics), with its VNA and 'Best in KLAS PACS' at its core — all delivered as a software-as-a-service. In booth #8113, Sectra will showcase its complete enterprise imaging portfolio comprised of diagnostic modules (radiology, cardiology, pathology, orthopaedics, ophthalmology and genomics), with its VNA and 'Best in...
PR Newswire
21/11/2024
Dreame launches Black Friday deals with up to £350 off
The X40 Ultra Complete offers exceptional cleaning efficiency in even the tightest spaces around the home. With Dreame's Mop Extend™ RoboSwing Technology and extendable side brush, the robot vacuum can remove dirt from under low furniture and in hard-to-reach corners, as deep as 4cm. It also has 12,000Pa Vormax™ Suction, swiftly lifting debris with fewer passes on hard floors and carpets. The X40 Ultra Complete offers exceptional cleaning efficiency in even the tightest spaces around the home...
PR Newswire
21/11/2024
BioWorld by Clarivate Highlights Gaps in Women's Health Research and Investment…
Women make up half of the global population, yet their health remains consistently underserved. Research and treatments have traditionally focused on reproduction and breast health, but these areas represent just a fraction of the broader health challenges women face. From autoimmune disorders to cardiovascular disease, many conditions disproportionately affect women or manifest differently than in men. However, decades of research have excluded women from clinical trials, often due to…
PR Newswire
21/11/2024
KFSHRC Madinah's Virtual Clinics Wins Award at PX Congress
Post-discharge virtual visits increased 155% from 2023 RIYADH, Saudi Arabia, Nov.20, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) in Madinah has been honoured with the Innovative Patient Care Solutions Award at the PX Congress 2024, held in Riyadh.Madinah's Nursing Affairs won the award for its Nurse-Led Post-Discharge Care Virtual Clinics, which exceeded targets with over 5,800 post-discharge virtual visits in 2024 (an increase of 155% from...
Nasdaq GlobeNewswire
21/11/2024
IBA Business Update – Third Quarter 2024
Louvain-la-Neuve, Belgium, 21 November 2024- IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its business update for the third quarter ending 30 September 2024.Group OverviewSolid equipment order intake at period-end of EUR 171 million, an increase from last year. Post-period, several major contracts finalized in Industrial Solutions to bring year to date order intake to EUR 215 millionStrong backlog conversion in the third...
Nasdaq GlobeNewswire
21/11/2024
DSM-Firmenich AG sold all of its stake in Robertet S.A.
For more information, please contact: For more information, please contact: dsm-firmenich investor relations enquiries:Email:
[email protected]
dsm-firmenich media enquiries:Email:
[email protected]
About dsm-firmenich As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With our comprehensive range of solutions,...
PR Newswire
21/11/2024
Novartis upgrades mid-term guidance and highlights deep pipeline in core…
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR 2023-2028 and +5% 2024-2029Strong momentum in the business with 8 in-market brands with USD 3bn+ to USD 8bn+ peak sales potential and 15+ near-term submission-enabling readouts 30+ high-value medicines in the pipeline expected to support continued mid-single digit sales growth beyond 2029 Basel, November 21, 2024– Today Novartis announced an upgrade to its mid-term guidance, in…
Nasdaq GlobeNewswire
21/11/2024
Chronic Refractory Cough Market Still Unexplored, with Pharma Companies Eyeing…
As per DelveInsight analysis, in 2023 the 12-month prevalent cases of chronic cough in the 7MM were estimated to be approximately 30 million cases, out of which the US accounted for nearly 13 million cases. These cases are expected to increase during the forecast period (2024–2034) driven by the aging population that has an increased likelihood of developing chronic conditions such as asthma, chronic obstructive pulmonary disease, and chronic cough. As per DelveInsight analysis, in 2023 the...
PR Newswire
20/11/2024
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah to Participate in the Piper Sandler 36 thAnnual Healthcare ConferenceMont-Saint-Guibert, Belgium – November 20, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the Company will participate in the Piper Sandler 36 thAnnual Healthcare Conference on Wednesday,...
Nasdaq GlobeNewswire
20/11/2024
Innocan Pharma Reports Third Quarter 2024 Financial Results
Financial Highlights Financial Highlights Management Comments Iris Bincovich, the CEO of Innocan commented : "As our results for both the third quarter and nine-month period have demonstrated, Innocan is bringing strong value for shareholders through our dual focus on our pharma and wellness activities. Chronic pain, which affects over a quarter of the U.S. population, remains one of the most pressing issues in outpatient care today*. Our commitment and solution for chronic pain...
PR Newswire
20/11/2024
Statement of total voting rights and shares forming the company's share capital…
Article R. 22-10-23 of the French Commercial Code Market : Euronext Paris ISIN code / Mnemo : FR0013233012 / IVA Web site :www.inventivapharma.comDateNumber of Shares Outstanding Total voting rights, gross(1) Total voting rights, net(2)November 4, 202487 077 695100 059 05299 938 530 The total number of gross (or “theoretical”) voting rights is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the...
Nasdaq GlobeNewswire
20/11/2024
Combined General Meeting of December 11, 2024 - Availability of the preparatory…
Daix (France), Long Island City (New York, United States), November 20, 2024– Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“ MASH ”), also known as non-alcoholic steatohepatitis (“ NASH ”), and other diseases with significant unmet medical needs, today announced the availability of the preparatory documents for the...
Nasdaq GlobeNewswire
20/11/2024
BerGenBio Appoints Olav Hellebø as CEO
"BerGenBio is at the forefront of exploring highly selective AXL inhibition as a therapeutic enhancement for the large number of patients with non-squamous non-small cell lung cancer with mutations in the STK11 gene. I am thrilled to join the company and look forward to collaborating with the board and team to advance the candidate drug, bemcentinib, through the next stages of clinical development and to take BerGenBio to the next phase", said Olav Hellebø. "BerGenBio is at the…
PR Newswire
20/11/2024
GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for…
"Adding automated aseptic fill-finish capabilities to our service offerings strengthens our ability to meet the diverse requirements of our clients, from start-up biotech to established pharmaceutical companies," said Karl Pinto, & CEO at GBI. "Our facility is equipped with state-of-the-art technology and a team of experts, capable of delivering high-quality, regulatory compliant drug products." "Adding automatedaseptic fill-finishcapabilities to our service…
PR Newswire
20/11/2024
The Gene Revolution: Transforming Lives through Gene Editing Therapeutics
This report takes a close look at the current and future possibilities of gene editing treatments and explores the factors that will help or hinder their use. It also examines the competitive landscape, including what therapeutics companies are working on and how they plan to bring new treatments to market. Additionally, it predicts how the market will evolve by 2029 and provides in-depth profiles of key players, including their business focus, financials, and products. This report takes a...
PR Newswire
20/11/2024
Plentiful Launches Digital Marketplace to Meet Rising Demand for Accessible…
Plentiful partners with a diverse range of practitioners including life and career coaches, nutrition and fitness specialists, relationship and parenting experts, and guides across many other wellness categories. Each practitioner offers experiences designed to help individuals or teams stop feeling stuck and reach their full potential. Plentiful partners with a diverse range of practitioners including life and career coaches, nutrition and fitness specialists, relationship and parenting...
PR Newswire
20/11/2024
Guidewires Market to Reach USD 1663.5 Million by 2030: Key Trends in Angled…
Claim Your Free Report: Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-28W15599/Global_and_India_Guide_Wires_Market Major Factors Driving the Growth of Guidewires Market: The guidewire market is growing rapidly due to rising demand for minimally invasive procedures and the increasing prevalence of chronic diseases. Key factors driving the market include advancements in guidewire technology, expanding healthcare infrastructure in emerging regions,...
PR Newswire
20/11/2024
Trading by management and close relations of management
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novozymes A/S, part of Novonesis Group reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B.Please read the full announcement in PDF. Attachment 2024_47_Trading_By_Management
Nasdaq GlobeNewswire
20/11/2024
AI's Growing Role in Transforming Healthcare Delivers Innovations in…
The article continued: Analysts at MarketsandMarkets Research forecast the AI in Healthcare Market to expand at a remarkable 48.1% CAGR, reaching $148.4 billion by 2029. With billions in investment pouring in, the World Economic Forum emphasizes the need for strategic spending, workforce adaptation, and proactive preparation to ensure these innovations achieve their full potential in reshaping global healthcare. The article continued: Analysts atMarketsandMarkets Researchforecast theAI in...
PR Newswire
20/11/2024
KOELIS announces the first interim results of the VIOLETTE trial which evaluates…
Recent advances in imaging technology have helped reduce the overdiagnosis and overtreatment of prostate cancer. The use of prostate MRI prior to the so-called “fusion” biopsy guided by MRI/ultrasound fusion imaging has proven its ability to visualize and accurately describe cancerous lesions on the way to a more personalized treatment.Thanks to the Koelis Trinity® fusion imaging system, a platform based on a disruptive technology called Organ-Based Tracking ®(OBT-Fusion), which...
Nasdaq GlobeNewswire
20/11/2024
COP29: Pricing gap means fashion remains amongst largest polluters globally -…
Fashion's high environmental impact has wide-reaching effects on climate, water and ecosystems. Its problems stem from multiple factors, particularly high costs and affordability. Fashion's high environmental impact has wide-reaching effects on climate, water and ecosystems. Its problems stem from multiple factors, particularly high costs and affordability. Marguerite Le Rolland, head of footwear and apparel at Euromonitor International, said:"Sustainable fashion requires investing in...
PR Newswire
20/11/2024
John Elway Teams Up with Endo to Share Update on Dupuytren's Contracture and…
Elway will speak to several media outlets on November 20, 2024 to detail his patient journey and provide an update on his current hand health. He believes he is feeling the beginning of Dupuytren's contracture in another finger, and he plans to request treatment with XIAFLEX again. Elway will speak to several media outlets onNovember 20, 2024to detail his patient journey and provide an update on his current hand health. He believes he is feeling the beginning of Dupuytren's contracture in...
PR Newswire
20/11/2024
Altri Comunicati
